Publish Time: 2024-06-25 Origin: Site
Timely and accurate diagnosis of infection from respiratory viruses is essential for managing clinical care and reducing transmission. Lateral flow tests, also referred to as rapid antigen tests, are point of care devices that can identify the presence of an infectious disease by detecting microbial proteins within 30 minutes. These assays leverage the principles of immunochromatography, where specific antibodies react with target antigens, producing a visible result on a test strip.
A recent comprehensive study, led by Professor Benjamin Cowling, the Chair of Epidemiology in University of Hong Kong (HKU), conducted in an outpatient clinic in Hong Kong highlights the exceptional performance of SARS-CoV-2 &Influenza A/B &RSV Antigen Kit (Colloidal Gold) manufactured by Goldsite Diagnostics Inc. (Short as Goldsite 4 in One Combo Rapid Test in the following context), making them an indispensable tool for healthcare professionals worldwide.
This paper suggests that multiplex rapid antigen tests are effective tools for diagnosing influenza, RSV, and SARS-CoV-2, offering a quick and reliable option for managing respiratory infections in clinical setting.
This study is supported by WHO Collaborating Centre for Infectious Disease Epidemiology and Control and Health and Medical Research Fund of Hong Kong SAR Government. As of 2024/06/25 when the article went public, this HKU study is a preprint and has not been peer reviewed.
The ability to rapidly and accurately diagnose multiple respiratory viruses is crucial for effective clinical management. Goldsite 4 in One Combo Rapid Test enable timely isolation and treatment decisions, thereby helping to curb the spread of respiratory virus infections.
The Hong Kong outpatient clinic study underscores the practical benefits of Goldsite 4 in One Combo Rapid Test. The tests were conducted in real-world settings, involving a diverse patient population. The study period was during the seasonal influenza epidemic in Hong Kong, with one epidemic peak in late April dominated by influenza A(H1N1) and a second peak in September dominated by influenza A(H3N2). An epidemic of SARS-CoV-2, dominated by Omicron XBB subvariants also occurred from April to July 2023 and therefore, the researchers expected the resulting PPV and NPV during periods of higher prevalence to be moderate to high.The findings reflect the 4 in One Combo Test Kit's robust performance across different age groups and varying viral loads, reinforcing their reliability in everyday clinical practice.
Goldsite 4 in One Combo Rapid Test stand out due to their proved superior sensitivity and specificity. They are designed to quickly and accurately identify the presence of multiple respiratory viruses, including influenza, RSV, and SARS-CoV-2, in a single test.
Goldsite 4 in One Combo Rapid Test exhibit sensitivity exceeding 84% for RSV and over 80% for influenza A and SARS-CoV-2. This high sensitivity ensures that even low levels of viral presence are detected, providing early and accurate diagnosis.
With specificity higher than 97%, Goldsite 4 in One Combo Rapid Test minimize false positives, ensuring that the diagnosis is both accurate and trustworthy. High specificity is crucial for avoiding unnecessary treatments and for reliable disease management.
Goldsite 4 in One Combo Rapid Test deliver results within 15 minutes, a critical factor in clinical settings where timely decisions can significantly impact patient outcomes. The rapid turnaround time allows healthcare providers to make swift and informed decisions, improving patient care and infection control.
The simplicity of Goldsite 4 in One Combo Rapid Test means they can be easily integrated into various clinical settings, from outpatient clinics to emergency departments. Their user-friendly design ensures that healthcare professionals can administer the tests efficiently without extensive training.
Goldsite 4 in One Combo Rapid Test solution stands out as a leading choice for the rapid and accurate detection of influenza, RSV, and SARS-CoV-2. Their high sensitivity and specificity, coupled with quick turnaround times, make them an invaluable asset in the fight against respiratory infections.
Healthcare providers looking for reliable and efficient diagnostic tools will find Goldsite 4 in One Combo Rapid Test to be an excellent choice, ensuring optimal patient care and effective infection control.
Trust in Goldsite – Your Path to Accurate Diagnostics.
Combo lateral flow tests, also referred to as combo rapid antigen tests, are diagnostic tools that can detect multiple pathogens in a single test using immunochromatography techniques.
4 in One means that the test kit is a combo test for detecting 4 pathogens, namely, SARS-CoV-2, Respiratory Syncytial Virus (RSV), Influenza A and Influenza B.
6 in One means that the test kit is a combo test for detecting 6 pathogens, namely, SARS-CoV-2, Mycoplasma pneumoniae (MP), Respiratory Syncytial Virus (RSV), Adenovirus (ADV), Influenza A and Influenza B.
Results can be obtained within 15 minutes, allowing for swift and informed clinical decisions.
Why is specificity important in diagnostics?
High specificity minimizes false positives, ensuring accurate diagnosis and preventing unnecessary treatments. Goldsite’s 4 in One and 6 in One combo tests report a higher specificity at 99%.
Yes, the simplicity and rapid turnaround time of Goldsite 4 in One and 6 in One combo tests make them suitable for various clinical settings, including outpatient clinics and emergency departments.
GOLDSITE DIGANOSTICS INC. is a leading manufacturer of IVD products dedicated to the healthcare sector. With over 25 years of expertise in the IVD industry, Goldsite has established itself as a trusted partner since 1999. With a team of experts in the field of diagnostics technology and a passion for improving healthcare, we strive to bring cutting-edge products to market that meet the evolving needs of health providers and patients. Engaged in R&D, manufacturing, and marketing of clinical laboratory devices and reagents, Goldsite has a portfolio of products covering specific proteins, chemistry, chemiluminescence, POCT platform, and associated reagents. All products live up to global standards with CE marking and have been exported to over 100+ countries.
For more information on Goldsite’s 4 in One and 6 in One combo test solutions and their applications in respiratory virus detection, visit the Goldsite’s official website: en.goldsite.com.cn
Follow our social media channels on Linkedin, X/Twitter, Facebook, TikTok, YouTube, and stay tuned for our latest news!
Home Products About Goldsite Support Solutions Download News Contact Us Privacy Policy